Search Results - "Fructuoso, Ferran José García"
-
1
Response to: "Interleukin-23 Blockade Is Not Effective in Axial Spondyloarthritis"
Published in Journal of clinical rheumatology (01-03-2024)Get full text
Journal Article -
2
A Randomized, Double-Blind, Placebo-Controlled Phase 2a Study of Tildrakizumab Efficacy and Safety in Patients With Active Ankylosing Spondylitis
Published in Journal of clinical rheumatology (01-08-2023)“…Tildrakizumab is an anti-interleukin-23p19 monoclonal antibody approved to treat moderate to severe plaque psoriasis. This study evaluated the efficacy and…”
Get full text
Journal Article -
3